Skip to content

Study · Animal study (in vivo) · mouse · 2013

3 results

The anti-wrinkle efficacy of Argireline.

Wang Y, Wang M, Xiao XS, Huo J, Zhang WD

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology6 Mar 2013Cited by 15 (Europe PMC)

PMID23464592 (opens in a new tab)DOI10.3109/14764172.2013.769273 (opens in a new tab)PepBankPUB-23464592
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In D-galactose-induced aged mice, Argireline improved skin histological structure.

    In plain wordsIn mice with induced aging, Argireline improved skin tissue structure.

    Peptide
    Argireline (acetyl hexapeptide-8)
    Outcome
    IncreaseSkin histological structure
    Study

    mousen: not reported in source

    D-galactose-induced aged mice
    Outcome group
    Skin and hair · Skin and wound
    Studied dose
    Dose not stated · topical · 6 weeksAs given in this study (mouse).

    Source sentences

    Summary
    There was an improvement in the histological structure of skin tissue in the aged mice; the amount of type I collagen fibers increased (P < 0.01), while that of type III collagen fibers decreased (P < 0.05).
    2 context sentences
    Summary · context
    To observe the effect of Argireline on histological changes in the skin in the aged mice induced by D-galactose.
    Summary · context
    Argireline was applied to the aged mice twice daily for 6 weeks.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In D-galactose-induced aged mice, Argireline increased type I collagen fibers.

    In plain wordsIn mice with induced aging, Argireline increased type I collagen fibers.

    Peptide
    Argireline (acetyl hexapeptide-8)
    Outcome
    IncreaseType I collagen fibers
    Study

    mousen: not reported in source

    D-galactose-induced aged mice
    Outcome group
    Skin and hair · Skin and wound
    Studied dose
    Dose not stated · topical · 6 weeksAs given in this study (mouse).

    Source sentences

    Summary
    There was an improvement in the histological structure of skin tissue in the aged mice; the amount of type I collagen fibers increased (P < 0.01), while that of type III collagen fibers decreased (P < 0.05).
    2 context sentences
    Summary · context
    To observe the effect of Argireline on histological changes in the skin in the aged mice induced by D-galactose.
    Summary · context
    Argireline was applied to the aged mice twice daily for 6 weeks.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In D-galactose-induced aged mice, Argireline decreased type III collagen fibers.

    In plain wordsIn mice with induced aging, Argireline decreased type III collagen fibers.

    Peptide
    Argireline (acetyl hexapeptide-8)
    Outcome
    DecreaseType III collagen fibers
    Study

    mousen: not reported in source

    D-galactose-induced aged mice
    Outcome group
    Skin and hair · Skin and wound
    Studied dose
    Dose not stated · topical · 6 weeksAs given in this study (mouse).

    Source sentences

    Summary
    There was an improvement in the histological structure of skin tissue in the aged mice; the amount of type I collagen fibers increased (P < 0.01), while that of type III collagen fibers decreased (P < 0.05).
    2 context sentences
    Summary · context
    To observe the effect of Argireline on histological changes in the skin in the aged mice induced by D-galactose.
    Summary · context
    Argireline was applied to the aged mice twice daily for 6 weeks.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:25 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.